Skip to content

Effects of a Whole Body Vibration Training in Patients After Lung Transplantation

Effects of a Whole Body Vibration Training on the Exercise Performance in Patients After Lung Transplantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01480960
Enrollment
140
Registered
2011-11-29
Start date
2012-01-31
Completion date
2015-12-31
Last updated
2016-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Following Lung Transplantation (Single and Double)

Keywords

lung transplantation, whole body vibration, exercise training, pulmonary rehabilitation

Brief summary

Pulmonary rehabilitation has been established as an evidence-based and recommended therapy in patients following lung transplantation. Exercise training has been shown to be a cornerstone of an inpatient rehabilitation program to reduce muscle dysfunction and improve exercise performance. In our study we will investigate the benefit of a whole body vibration training in addition to a standard pulmonary rehabilitation program that includes endurance and strength training. We will include a total of 140 patients (70 patients \< 1 year after lung Transplantation and 70 patients \> 1 year after lung Transplantation). Our hypothesis is that an addtitional whole body vibration training produces a greater benefit to exercise capacity in lung transplantat patients (LTx).

Interventions

OTHERPulmonary rehabilitation + whole body vibration training

standard inpatient rehabilitation program including endurance and strength plus squats on a vibration plate for 4x2 minutes, 3 times per week

Sponsors

Schön Klinik Berchtesgadener Land
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* participation in an inpatient rehabilitation program * double or single lung transplantation due to chronic obstructive pulmonary disease, Alpha-1-antitrypsine deficiency, interstitial lung disease

Exclusion criteria

* severe exacerbation in the last 4 weeks with the necessity of delivering antibiotics/ corticosteroids * non-compliance

Design outcomes

Primary

MeasureTime frame
change in 6-minute walking distancechange from baseline to day 21

Secondary

MeasureTime frameDescription
change in Fmaxchange from baseline to day 21maximum isometric quadriceps force
change in fibre cross sectional areachange from baseline to day 21cross sectional area of the M.rectus femoris, measured by ultrasound
change in chair rise timechange from baseline to day 21chair rise test: to get from a sitting position to a standing, measuring the time for 5 repetitions
change in Wmaxchange from baseline to day 21maximum workload in incremental cycling test
change in body cell masschange from baseline to day 21measured by bio-impedance analysis
change in IGF-1change from baseline to day 21IGF-1, measured in a blood sample
change in quality of lifechange from baseline to day 21SF-36 questionnaire and CRQ questionnaire

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026